These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 9095420)

  • 21. Determination of Optimal Amikacin Dosing Regimens for Pediatric Patients With Burn Wound Sepsis.
    Yu T; Stockmann C; Healy DP; Olson J; Wead S; Neely AN; Kagan RJ; Spigarelli MG; Sherwin CM
    J Burn Care Res; 2015; 36(4):e244-52. PubMed ID: 25185930
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of once daily tobramycin dosing in critically ill patients through Bayesian simulation.
    Peris-Marti JF; Borras-Blasco J; Rosique-Robles JD; Gonzalez-Delgado M
    J Clin Pharm Ther; 2004 Feb; 29(1):65-70. PubMed ID: 14748900
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Once-daily aminoglycoside dosing: impact on requests and costs for therapeutic drug monitoring.
    Nicolau DP; Wu AH; Finocchiaro S; Udeh E; Chow MS; Quintiliani R; Nightingale CH
    Ther Drug Monit; 1996 Jun; 18(3):263-6. PubMed ID: 8738765
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of multiple courses of therapy on aminoglycoside clearance in adult patients with cystic fibrosis.
    Alghanem S; Paterson I; Touw DJ; Thomson AH
    J Antimicrob Chemother; 2013 Jun; 68(6):1338-47. PubMed ID: 23435691
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Extended-Interval Dosing of Gentamicin Aiming for a Drug-Free Period in Neonates: A Prospective Cohort Study.
    van Maarseveen EM; Sprij A; Touw DJ
    Ther Drug Monit; 2016 Jun; 38(3):402-6. PubMed ID: 26836810
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Serum level-adjusted dosage of once-daily aminoglycoside therapy in critical illness: results of a prospective study].
    Reimann IR; Meier-Hellmann A; Pfeifer R; Traut T; Schilling A; Stein G; Reinhart K; Hoffmann A
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1999 May; 34(5):288-95. PubMed ID: 10372218
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monitoring of a single post-infusion blood sample to estimate the actual peak and trough concentration of tobramycin in critically ill patients.
    Reimann IR; Meier-Hellmann A; Traut T; Reinhart K; Hoffmann A
    Exp Toxicol Pathol; 2003 Jun; 54(5-6):493-8. PubMed ID: 12877363
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aminoglycoside monitoring program.
    Vakoutis J; Stein GE; Miller PB; Clayman AE
    Am J Hosp Pharm; 1981 Oct; 38(10):1477-80. PubMed ID: 7294041
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of gentamicin and tobramycin nephrotoxicity in patients receiving individualized-pharmacokinetic dosing regimens.
    Pancorbo S; Compty C; Heissler J
    Biopharm Drug Dispos; 1982; 3(1):83-8. PubMed ID: 7082782
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative justification for target concentration intervention--parameter variability and predictive performance using population pharmacokinetic models for aminoglycosides.
    Matthews I; Kirkpatrick C; Holford N
    Br J Clin Pharmacol; 2004 Jul; 58(1):8-19. PubMed ID: 15206987
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of higher dose extended interval aminoglycosides in a neonatal intensive care unit.
    Ohler KH; Menke JA; Fuller L
    Am J Perinatol; 2000; 17(6):285-90. PubMed ID: 11144309
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Determinants of gentamicin concentrations in critically ill patients: a population pharmacokinetic analysis.
    Hodiamont CJ; Juffermans NP; Bouman CS; de Jong MD; Mathôt RA; van Hest RM
    Int J Antimicrob Agents; 2017 Feb; 49(2):204-211. PubMed ID: 28038961
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Systematic Review of Vancomycin Dosing and Monitoring in Burn Patients.
    Carter BL; Damer KM; Walroth TA; Buening NR; Foster DR; Sood R
    J Burn Care Res; 2015; 36(6):641-50. PubMed ID: 25423436
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of once-daily versus pharmacokinetic dosing of aminoglycosides in elderly patients.
    Koo J; Tight R; Rajkumar V; Hawa Z
    Am J Med; 1996 Aug; 101(2):177-83. PubMed ID: 8757358
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Randomized controlled trial of once- versus thrice-daily tobramycin in febrile neutropenic children undergoing stem cell transplantation.
    Sung L; Dupuis LL; Bliss B; Taddio A; Abdolell M; Allen U; Rolland M; Tong A; Taylor T; Doyle J
    J Natl Cancer Inst; 2003 Dec; 95(24):1869-77. PubMed ID: 14679156
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased dosage requirements of gentamicin in burn patients.
    Zaske DE; Sawchuk RJ; Gerding DN; Strate RG
    J Trauma; 1976 Oct; 16(10):824-8. PubMed ID: 994263
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Once-daily gentamicin dosing in children with febrile neutropenia resulting from antineoplastic therapy.
    Inparajah M; Wong C; Sibbald C; Boodhan S; Atenafu EG; Naqvi A; Dupuis LL
    Pharmacotherapy; 2010 Jan; 30(1):43-51. PubMed ID: 20030472
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of aminoglycoside dosing and estimated glomerular filtration rate in determining gentamicin and tobramycin area under the curve and clearance.
    Lim AK; Mathanasenarajah G; Larmour I
    Intern Med J; 2015 Mar; 45(3):319-29. PubMed ID: 25581282
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetic dosing of aminoglycosides: a controlled trial.
    Bartal C; Danon A; Schlaeffer F; Reisenberg K; Alkan M; Smoliakov R; Sidi A; Almog Y
    Am J Med; 2003 Feb; 114(3):194-8. PubMed ID: 12637133
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics of once-daily gentamicin dosing in pediatric patients.
    Bass KD; Larkin SE; Paap C; Haase GM
    J Pediatr Surg; 1998 Jul; 33(7):1104-7. PubMed ID: 9694103
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.